Review of Retail Drug Store Readiness in Competive Position for ASEAN ECONOMIC COMMUNITY

2
5
6
9
10
ASEAN
19
6
29
1. (Procurement system)
29
2. (Logistic and supply chain)
31
3. (Management skill)
42

3
4. (Professional service)
44
5. (Human resource & career
development) 48
6. (Information technology)
49
AEC 52
54
55
56

4
1 The Total Market Pharmaceutical Market Share by Channels
10
2 Environment Scanning Mat Audit Market Trend
11
3 Multinational vs. Local Manufacturers
11
4 Growth Total Market
12
5 2554
12
6 Chain Store
13
7 7-11
13
8
14
9 - 5
15

5
10 5
15
11 5
22
12
22
13 Pharmaceutical Supply Chain
31
14 Global Supply Chain: An evolving Model
32
15 ABCD: FOUR LENSES for looking Supply Chains
33
16 Distribution Models in ASIA Pharma Market (Under Pressure)
34
17 Trends and Development in Thailand Market MNC Members in
1987 35
2006 36

6
2010 36
20 Trends and Development in Thailand Market Distributors in 1970’s
37
37
38
23 Distribution Models in ASIA Pharma Market (under pressure)
40
23
44
24
44
25 Levels of Product and Services
46
26 Creating a Framework for Pharmacy Service
48

7
27 Four major activities of information management for Modern
Healthcare Organization 51
2378 178
50%

8
2558
“ ” :
“
”
6 1.
(Procurement system), 2.
(Logistic and supply chain), 3. (Management skill), 4.
(Professional service), 5.
(Human resource & career
development), 6. (Information technology)

9
6
2378
2479 2 2510
1
3
1. ( 1)
2.
( 2)
3.

10
2522 2510
5
3
2530 5
2535
4 2527
3
30 2529
2540
2544

11
10 chain
drugstores ( ) franchised drugstores
( )
( :2542)
14(3)
( :2548)

12
:
6
5. (Human resource & career
development)

14
The Total Market
Pharmaceutical Market Share by Channels
Total Market
110 Bn.THB
%Gr. 1
Total OTC
24 Bn.THB
%Sh. 22
Total MC
86 Bn.THB
%Sh. 78
326Local
174Multinational
% Gr.% Sh.
1. Environment Scanning)
2. (Drugstore Competition Analysis)
1. Environment Scanning)

15
1 The Total Market Pharmaceutical Market Share by Channels
2554
110,000
1% 3%
24,000 7 %
42% 2%
11%
76% 5%
17% -10%
7%
3%

16
Environment Scanning
: Business Unit Director, Sales and Marketing Division, Zuellig Pharma
2 Mat Audit Market Trend
Nano MBA 2555
8%
4,600

17
4 Growth Total Market
3 Multinational Vs Local Manufacturers

18
5 2554
2554 11,603
3,923 (33.81%) 7,680
(64.19%)
2552
Boots 200
7/11
7/11
7,000

19
6 Chain Store
7 7-11

20
2. (Drugstore Competition Analysis)
Five Force
Model in Competition Analysis Michael Porter
1.
2.
3.
4.
5.
8
1.
6.8%
4.7%

21
9 -
5
2.
-
:
0
50
100
150
200
250
300
350
400
2551 2552 2553 2554 2555

22
10
5
0
20
40
60
80
100
120
140
160
2551 2552 2553 2554 2555
:
:
:
25
: 25-35
: 100,000-200,000

23
1
600,000-800,000
( : : 2548)
70 % 30 %
AEC 2558
2,200

24
3.
-
E-
Commerce.
30
convenience
store
House Brands
Beauty Care and Nutritional Supplement
Modern

25
E-Pharmacy
Internet
4.
5.
2 Original
Local made

27
ASEAN
2558 ASEAN
“ ”
“
FTA (Threat or
Opportunity) (External Factors)
(Awareness)

28
AEC
(ASEAN Free Trade Area: AFTA1) AFTA
0
(Rules of
Origin: ROO)
-
GMP 0 %
,
%
1 ASEAN Free Trade Area: AFTA 5
6 4
10 AFTA
(ASEAN Economic Community:
AEC) 3 10 (ASEAN Community: AC)
2558

29
(Non-tariff Barrier: NTB)
NTB
[ASEAN Harmonization]
Logistic

30
ChainDrugstores
Procurement Logistic
–
( -
(Economic
Union)
AEC
( )
( )

31
Negative List Approach 2
Negative List
Air Transport,
Information Technology and Telecommunication (e-ASEAN), Healthcare, Tourism, Logistics
3
Negative List
2 ASEAN Comprehensive Investment
Agreement: ACIA 70
100
Negative List
50
3 12 “Priority
Integration Sectors (PIS)” Agro-based goods, air transport, automotive products, e-
ASEAN, electronics and electrical goods,fisheries, health care services, rubber-based goods,
textiles and clothing, tourism, logistics and wood-based products

33
12
Quality Process or
professional Services Quality System
(Healthcare)

34
4 (CPC 9311 9319 93191
933)
(Domestic Regulation)
(Permanency Changes)
[Professional Management] [Professional
Service]
4 5 4 2553
(The 5th Package of Commitments under ASEAN Framework Agreement on Services)
(CPC 9311 9319 93191 933)
2558

35
(Mutual Recognition Arrangement: MRA)
Mode of Supply)
GATS (General Agreement on Trade in Services) (World
Trade Organization: WTO) 5
5 2015
 Mode 1
 Mode 2
 Mode 3 %
( %) ( %)
( %) ( %) ( %)
%
 Mode 4
( )
MRA 8

36
(Natural Person)
(Skilled Labor) (Professionals)
(Skilled Labor)
(Professionals)
(Mutual Recognition
Arrangement: MRA)
: MRA
ASEAN Joint
Coordinating Committee on Medical Practitioners

37
Rx / Rx
1Rx :
IMF2011) 64.08 16 1900 29,987 1 : 2137
(2012) 103.76 28 n.a. 60,293 1 : 2721
(2012) 5.35 4 162 1,962 1 : 2727
(2010) 29.18 15 7,298 1 : 3998
(2012) 91.52 3 n.a. 16,107 1 : 5682
(2012) 242.33 63 4000 40,000 1 : 6058
(IMF2011) 14.31 1 n.a. 2,000 1 : 7155
(IMF2011) 0.41 1 n.a 48 1 : 8516
(2004) 54.58 2 n.a. 136 1 : 401324
(IMF2011) 6.59 1 n.a n.a. n.a.
612.11 134 157,831 1 : 3878

39
Regulator
Conformity Assessment Technical Infrastructure)
Mutual
Recognition Arrangement: MRA

40
ASEAN Joint Coordinating Committee on
Pharmaceutical Practitioners
Modern Trade

41
(
Mode 1Cross Border Supply)
Internet
(Mode
2Consumption Abroad)
OTOP
WTO

42
Mode
1
(Mode 1) (Mode 2)
”
( :
.
2556)
6

43
5. (Human resource & career development)
2

44
“ ”
35 1 51 – 52
1) 2
2548-2549
2548
3.39 2549 25.33

45
2)
2
Karunya
Community Pharmacy 20-
60%
Karunya Pharmacy
Karunya
2,500 Karunya
4 Gujarat, Karnataka, Rajasthan and Tamil
Nadu
2

46
13 Pharmaceutical Supply Chain
2. (Logistics and supply chains)
(Warehouse) (Transportation)
20
Logistics and Supply Chains Management
3

47
1(Global Supply Chain 1.0)
Vertical Integration
Ford Motor 1985-1995
(Globalization)
2
2(Global Supply Chain
2.0) 2
1995-2005 (Horizontal
Integration)
TOYOTA MOTOR
Internet
Online
3
3(Global Supply Chain 3.0) 2005 –

48
14 Global Supply Chain: An evolving Model
(Mapped Network)
Cloud Computing
Dells Computer, Google Inc.

49
4
1. (Business Model): Global Supply Chain
2. (Architecture): Asia 2020
2020
3. (Direction and Policy): Governance
4. (Context): Asia’s Sustainable Development

50
15 ABCD: FOUR LENSES for looking Supply
Chains

51
16 Distribution Models in ASIA Pharma Market (under
pressure)

52
Trends and Development in Thailand Market
MNC Members in 1987 (4,017 Mn.Bt.)
1. Roche Thailand
2. Hoechst Thai
3. Merck Sharp & Dome
4. Glaxo
5. Thai Otsuka Pharmaceutical
6. Ciba-Geigy
7. Sandoz (T) Ltd.
8. Schering
9. Smith Kline & French
10. Warner Lambert
11. Astra
12. Pfizer International
13. Westmont
14. Eli Lilly
15. Squibb
16. Richardson-Vicks
21. Bayer Thai
22. Paiboon Watana (Takeda)
23. Bristol Myers
24. Wellome Thailand
25. Boehringer Ingelheim
26. Organon (T) Ltd.
27. Farmitalia Carlo Erba
28. ICI Products
29. Merrell Dow
30. Upjonh Co.,Ltd
31. Medimpex
32. Beecham
33. Sterling Drug
34. Roussel
35. Essex Thailand
36. G.D. Searle
41. Abbott Lab. Ltd.
42. Sanofi
43. Hausmann
44. United A. Pharm.
45. Syntex
46. Mack
47. Biomedis
48. Degussa
49. Unichem
50. Eisai
51. Stuart
52. Carter Wallace
53. Pliva
54. Menarini
55. Nattermann
1.
2.
3.
4.
5.
6.
40

53
64
5. Roche
2. Hoechst Thai
6. MSD
3. GlaxoSmithKline
27. Thai Otsuka
6. Ciba-Geigy
7. Novartis
9. Schering (Bayer Schering)
10. Warner Lambert
4. AstraZeneca
1. Pfizer
21. Great Eastern Drug
14. Eli Lilly
15. Squibb
16. Richardson-Vicks
17. May & Baker / Nattermann
18. Boots
8. Janssen -Cilag
12. Schering-Plough
16. Bayer Thai (Bayer Schering)
10. Takeda
11. Bristol-Myers Squibb
15. Organon (T) Ltd.*
• Farmitalia Carlo Erba
28. ICI Products
29. Merrell Dow
30. Upjonh Co.,Ltd
31. Medimpex
32. Beecham
33. Sterling Drug
34. Roussel
35. Essex Thailand
36. G.D. Searle
37. Les Lab Servier
38. Boehringer Mannheim
20. Merck
18. Wyeth-Ayerst / Consumer
14. Abbott
2. Sanofi-Aventis Group
43. Hausmann
45. Syntex
46. Mack
47. Biomedis
48. Degussa
49. Unichem
17. Eisai
51. Stuart
52. Carter Wallace
53. Pliva
54. Menarini
55. Nattermann
19. Servier
22. UCB Pharma
23. Thai Meiji
24. Baxter Healthcare
25. Solvey Pharma
26. Astellas
28. Daiichi Sankyo
29. Fujisawa
* acquired by SP in 2007 Source : PReMA Open Sales Exchange- December 2006
1987
2006
6. Roche
2. Hoechst Thai
2. MSD
4. GlaxoSmithKline
19. Thai Otsuka
6. Ciba-Geigy
5. Novartis
9. Schering (Bayer Schering)
8. Bayer Schering
9. Takeda
13. Bristol-Myers Squibb
15. Organon (T) Ltd.*
• Farmitalia Carlo Erba
28. ICI Products
29. Merrell Dow
14. Abbott
3. Sanofi-Aventis Group
43. Hausmann
45. Syntex
46. Mack
47. Biomedis
48. Degussa
49. Unichem

54
Contract Distribution In-house Distribution
Asian TJD Enterprise (Thailand) Ltd Bayer Thai Co.,Ltd.*
Bara Winsor Boots (Thailand) Ltd.*
BJC Trading (Berli Jucker) Bristol-Myers (Thailand) Co., Ltd.
B.Grimm & Co.,R.O.P Carlo Erba (Thailand) Co. Ltd.
B.L.H Trading Co.,Ltd Dumex Ltd.*
Bangkok-Swiss Trading Co Glaxo (Thailand) Ltd.*
IDS (Marketing) (Boeno) Great Eastern Drug Co.,Ltd
Diethelm & Co.,Ltd Hoechst Thai Ltd
East Asiatic Co.,Ltd Mason (Thailand) Co,Ltd (Parke Davis)
International Pharmaceutical May & Baker Ltd
Jack Chia & Co.,Ltd Paiboon Watana Co.,Ltd. (Takeda)
L & Sons Pfizer International Corpn. (S.A)
OLIC (Thailand) Ltd. (Lepetit) Richardson-Marrell (Thailand) Ltd
Muller & Phipps (Thailand) Schering (Bangkok) Ltd
New French Dispensary Ltd Squibb Far East Ltd
Smith Kline & French Ltd Sterling Drug International
U.S Summit Corp
Pacific HealthCare(Pacific Investment)
Wheelock Marden & Co. (Thailand) Ltd
Zuellig Pharma (F.E Zuellig)
Trends and Developments in Thailand Market
Distributors in 2007
Source : MIM -2007
Berli Jucker (BJC Trading) Bristol-Myers (Thailand) Co., Ltd.
Boeno (Thailand) Ltd (IDS Marketing) Great Eastern Drug Co.,Ltd
Diethelm & Co.,Ltd Hoechst Thai Ltd
Lepetit (Thailand) Co,.Ltd (OLIC (Thailand) Ltd Richardson-Marrell (Thailand) Ltd
U.S Summit Corp
Pacific Investment (Pacific HealthCare)
Zuellig F.E.(Bangkok) Ltd
Distributors in 1970’s
Source : TIM -1970

55
BJC Trading (Berli Jucker) Bristol-Myers (Thailand) Co., Ltd.
IDS (Marketing) (Boeno) Great Eastern Drug Co.,Ltd
DKSH Hoechst Thai Ltd
OLIC (Thailand) Ltd. (Lepetit) Richardson-Marrell (Thailand) Ltd
U.S Summit Corp
Pacific HealthCare(Pacific Investment)
Zuellig Pharma (F.E Zuellig)
Distributors in 2010
Source : MIM -2010

56
:
(Order cycle time)
(Delivery timeliness)
(Frequency of delivery)
(Call-out time)
(Response time)
(Accessibility)
(Delivery completeness and
reliability)
(Accuracy on
invoices, delivery notes etc.)
(Stock availability)
(Ordering convenience)
(Customer service policy)
(System flexibility)
(Order size constraint)

57
(Customer complaints
and claims)
(Status information)
:
:
o
o
o
:
o
o
o
o
o

58
23 Distribution Models in ASIA Pharma Market (under pressure)
The
sustainability of supply chain-lessons from the EU,18 September 2012
Speed
• Order cycle time
• Delivery timeliness
• Frequency of delivery
• Call-out time
• Response time
• Daily access on :
- sales
- customer
- inventory
• Timely and accurate report
• Accessibility
• Delivery completeness and
reliability
• Accuracy on invoices, delivery
notes, C/N etc
• Stock availability
• Ordering convenience
• Integrated part of any business
process :
- sales & marketing
- business development
- logistic
- finance
- IT
• On-time payment
• Customer service policy
• system flexibility
• Order size constraint
• Customer complaints and claims
• Status informations
• Market intelligence
• On-site office space
CUSTOMER PRINCIPAL
Distribution Models in ASIA Pharma Market (under
pressure)
: : Pharmaceutical Marketing Handout 2012
71

59
22 . . 2013 Bloomberg
Walgreen
Global Alliance Boots GmbH
AmerisourceBergen Crop
TIMOTHY W.MARTIN,Bloomberg
News,March 22,2013
Thesis The Pharmaceutical Supply Chain : a Diagnosis of the
State-of-the-art Mahender Singh Engineering Logistic, Massachusetts Institute of
Technology, USA
Networked Pharmaceutical Supply Chain
3
Distributor
Margin based profit sharing business model Block Buster Video
Model
Cloud system

60
“ ”
(Supply Chain)
” Retailing Management for
Community Pharmacist 2556

61
Modern Management
• Retailing Management
• Entrepreneurship
Management
• Marketing Management)
• Service Management
• Operation Management
• Quality Management
• Human Resource Management
•

62
23
24

63
Professional service
-
-
-
-
-
-
-
-
Krittin Bunditanukul Pharm.D, BCPS Department of Pharmacy Practice, Faculty of
Pharmaceutical Science, Chulalongkorn University
“ ”
common ilness

64
“ ”
“ ”
product service
information service
3
1.
2.
3.

65
Levitt’s Total Product/Service Model
25 Levels of Product and Services
Levitt’s Total Product/Service Model
“
Potential Product/Service
Augmented
Product/Service
Expected
Product/Service
Generic Core Product/Service ”

66
- Medication Therapy Management (MTM)
- Immunization
- Adherence
- Chronic Disease
-
The Value of Pharmacist Professional Service in
the Community Setting, A systematic review of the literature 1990-2002

67
26 Creating a Framework for Pharmacy Service
Pharmacy Professional Service
Source: Canadian Pharmacy Service Framework, October 2011

68
Drug Therapy 3
3
1. Enhance medication related
services
2. Coredispensing services
3. Expanded patient
care services
5. (Human resource & career development)
19

69
2000
2018
Continue Pharmacy Education, CPE

70
“ ”
Smart Phone/Tablet:
Social Media and Community: Facebook Twitter Socialcam
Social media
High-Speed Internet: 3G

71
I-Cloud Storage:
3
RFID Radio Frequency Identity), QR Code (Quick Response Code), AR
(Augmented Reality):
AEC holds huge opportunities for
Pharmaceutical industry in Southeast Asia By Admin@pharmexasia On January 4, 2013
2015

72
E-Commerce
4
The Well-Manage Healthcare Organization
1. Service Line
Support:
2. Clinical Service
Support:
3. Management Support:
4. Network of I/O devices:
Four major activities of Information management for
Modern Healthcare Organization
EMR
Service
Line
Support
Management
Support
Network of I/O devices
Clinical
service
support
Ophthalmology,
Pediatric, IVF,
etc.
Nursing,
Pharmacy,
pathology,
operation room,
rehabilitation
Accounting,
purchasing,
inventory,
Marketing,
Human
resource.
Record patient
condition, order
diagnostic tests,
treatments, results
Source: The Well-Managed Healthcare Organization (Kenneth R. White, PhD, John R. Griffith,
FACHE , 2010)

73
27 Four major activities of information management for Modern
Healthcare Organization
6

75
:
refill
/ :
IT, Smart Phone etc.:
R&D:
:

78
. .
“
SMEs
%
% %
,
,
,
(Retail Store)
Chain Drugstore
24
One Stop Service

79
Economy of Scale
Chain Drug Store
“
.
2556
2.
35 1 51 – 2552

80
The Pharmaceutical Supply Chain: a Diagnosis of the State-of-the-
art. Master Thesis by Mahender Singh. Engineering Logistic,
Massachusetts Institute of Technology, USA. June 2005
Retailing Management for Community Pharmacist
2556
Krittin Bunditanukul Pharm.D, BCPSDepartment of Pharmacy
Practice, Faculty of Pharmaceutical Science, Chulalongkorn
University
The sustainability of supply chain-lessons from the EU, 18 September
2012
The Value of Pharmacist Professional Service in the Community
Setting, A systematic review of the literature 1990-2002
Canadian Pharmacy Service Framework, October 2011
TIMOTHY W.MARTIN, Bloomberg News, March 22, 2013

Review of Retail Drug Store Readiness in Competive Position for ASEAN ECONOMIC COMMUNITY

Recommended

Recommended

More Related Content

Similar to Review of Retail Drug Store Readiness in Competive Position for ASEAN ECONOMIC COMMUNITY

Similar to Review of Retail Drug Store Readiness in Competive Position for ASEAN ECONOMIC COMMUNITY (20)

Recently uploaded

Recently uploaded (20)

Review of Retail Drug Store Readiness in Competive Position for ASEAN ECONOMIC COMMUNITY